During the past decade, Albany Medical College, Division of Community Endocrinology conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 7 clinical trials were completed, i.e. on average, 116.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Albany Medical College, Division of Community Endocrinology" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Pfizer" with 3 trials sponsored, "Akebia Therapeutics" with 1 trials sponsored, "Medtronic Diabetes" with 1 trials sponsored and "Radius Health, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Albany Medical College, Division of Community Endocrinology" #1 collaborator was "Cyclerion Therapeutics" with 1 trials as a collaborator and "Locemia Solutions ULC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Albany Medical College, Division of Community Endocrinology" are "Cardiovascular Disease" (2 trials), "Type 2 Diabetes" (2 trials), "Diabetes Mellitus" (1 trials), "Drug-Specific Antibodies" (1 trials) and "Hyperlipidemia" (1 trials). Many other conditions were trialed in "Albany Medical College, Division of Community Endocrinology" in a lesser frequency.

Most popular intervention types in "Albany Medical College, Division of Community Endocrinology" are "Drug" (8 trials), "Combination Product" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Tirzepatide" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Bococizumab (PF-04950615; RN316)" (1 trials) and "IW-1973" (1 trials). Other intervention names were less common.

The vast majority of trials in "Albany Medical College, Division of Community Endocrinology" are 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Albany Medical College, Division of Community Endocrinology". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Albany Medical College, Division of Community Endocrinology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Albany Medical College, Division of Community Endocrinology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".